Aratana Therapeutics Inc (NASDAQ:PETX)

5.08
Delayed Data
As of Apr 20
 +0.11 / +2.21%
Today’s Change
3.67
Today|||52-Week Range
7.67
-3.42%
Year-to-Date

Today’s Trading

Previous close4.97
Today’s open4.95
Day’s range4.86 - 5.12
Volume345,502
Average volume (3 months)483,465
Market cap$183.2M
Data as of 4:00pm ET, 04/20/2018

Growth & Valuation

Earnings growth (last year)+61.22%
Earnings growth (this year)-7.07%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+5,585.99%
P/E ratioNM
Price/Sales6.57
Price/Book1.73

Competitors

 Today’s
change
Today’s
% change
FBIOFortress Biotech Inc-0.10-2.33%
CPRXCatalyst Pharmaceuti...-0.03-1.18%
DRRXDURECT Corp-0.03-1.40%
SBBPStrongbridge Biophar...+0.05+0.66%
Data as of 4:00pm ET, 04/20/2018

Financials

Next reporting dateMay 4, 2018
EPS forecast (this quarter)-$0.19
Annual revenue (last year)$38.6M
Annual profit (last year)-$33.6M
Net profit margin-87.09%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Steven St. Peter
Chief Operating Officer
Brent A. Standridge
Corporate headquarters
Leawood, Kansas

Forecasts